These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36602989)

  • 1. Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani.
    Wijesooriya H; Samaranayake N; Karunaweera ND
    PLoS One; 2023; 18(1):e0270722. PubMed ID: 36602989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Insight Into Systemic Immune Response in
    Thakur L; Madaan P; Jain A; Shankar V; Negi A; Chauhan SB; Sundar S; Singh OP; Jain M
    Front Immunol; 2021; 12():765684. PubMed ID: 35087516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of TNFalpha and IL-18 in human peripheral blood mononuclear cells infected with Leishmania major or Leishmania donovani.
    Iannello D; Arena A; Buemi C; Calapai M; Stassi G; Gazzara D; Mastroeni P
    New Microbiol; 2003 Oct; 26(4):399-404. PubMed ID: 14596352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis.
    Oliveira WN; Ribeiro LE; Schrieffer A; Machado P; Carvalho EM; Bacellar O
    Cytokine; 2014 Apr; 66(2):127-32. PubMed ID: 24485388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
    Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
    Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
    J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mediators in human leishmaniasis: Critical determinants in parasite killing or disease progression.
    Divenuto F; Marascio N; Quirino A; Giancotti A; Filice S; Gigliotti S; Campolo MP; Campolo M; Barreca GS; Lamberti AG; Castelli G; Bruno F; Matera G
    Acta Trop; 2023 Dec; 248():107037. PubMed ID: 37805040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unwinding the mechanism of macrophage repolarization potential of
    Jayaraman A; Srinivasan S; Uppuluri KB; Kar Mahapatra S
    Front Cell Infect Microbiol; 2023; 13():1120888. PubMed ID: 37033485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of Th1-type responses in mucosal leishmaniasis patients.
    Bacellar O; Lessa H; Schriefer A; Machado P; Ribeiro de Jesus A; Dutra WO; Gollob KJ; Carvalho EM
    Infect Immun; 2002 Dec; 70(12):6734-40. PubMed ID: 12438348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
    Jafarzadeh A; Jafarzadeh S; Sharifi I; Aminizadeh N; Nozari P; Nemati M
    Cytokine; 2021 Nov; 147():155321. PubMed ID: 33039255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin induces the phagocytosis and protective immune response in Leishmania donovani infected THP-1 cell line and human PBMCs.
    Dayakar A; Chandrasekaran S; Veronica J; Maurya R
    Exp Parasitol; 2016 Jan; 160():54-9. PubMed ID: 26688099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
    Melby PC; Chandrasekar B; Zhao W; Coe JE
    J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.
    Khare P; Jaiswal AK; Tripathi CD; Joshi S; Sundar S; Dube A
    Parasitol Res; 2014 Mar; 113(3):851-62. PubMed ID: 24370734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 and TGF-β Induced Arginase Expression Contributes to Deficient Nitric Oxide Response in Human Visceral Leishmaniasis.
    Kupani M; Sharma S; Pandey RK; Kumar R; Sundar S; Mehrotra S
    Front Cell Infect Microbiol; 2020; 10():614165. PubMed ID: 33680983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.
    Galdino H; Maldaner AE; Pessoni LL; Soriani FM; Pereira LI; Pinto SA; Duarte FB; Gomes CM; Fleuri AK; Dorta ML; de Oliveira MA; Teixeira MM; Batista AC; Joosten LA; Vieira LQ; Ribeiro-Dias F
    BMC Infect Dis; 2014 May; 14():249. PubMed ID: 24884781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.
    Singh OP; Gidwani K; Kumar R; Nylén S; Jones SL; Boelaert M; Sacks D; Sundar S
    Clin Vaccine Immunol; 2012 Jun; 19(6):961-6. PubMed ID: 22539471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.